At a glance
- State whether a score is decorative or intended for splitting.
- Evaluate actual portions using the intended product and method.
- Align the score design, evidence, and directions.
Explain why the score line is proposed
A groove can be requested for visual identity, handling, or an intended split portion. State the purpose at the start of development. If the consumer is meant to divide the tablet, the project needs a different evidence discussion from a tablet with a decorative surface feature. Do not allow the sample appearance to imply an unreviewed use.
Ask the team to connect the proposed design to the complete formula, tablet shape, dimensions, and serving concept. If splitting is part of the intended directions, make that visible to the label reviewer. A manufacturing drawing can define the groove geometry, but it cannot independently establish the characteristics of the resulting portions.
Distinguish a groove from a verified function
An FDA laboratory study of pharmaceutical tablets found that splitting outcomes depended on product characteristics and the splitting method. This is drug research, not a supplement approval standard. It provides a reason to evaluate the intended function in the actual product rather than assuming a visible score guarantees equal portions.
Request an assessment plan for the proposed tablet and intended way of dividing it. Ask how portion consistency, loss of material, appearance, and any relevant ingredient measurements will be reviewed. The technical team should identify appropriate evidence and methods. The buyer’s role is to make the intended consumer use and commercial requirements clear.
Plan representative sample evaluation
Use samples made with the intended formula and identified tooling when assessing a functional score. Record how the tablet was divided and preserve examples where practical. If the first prototypes use another composition, clearly label their limitations. A placeholder sample may help discuss geometry without representing the performance of the final product.
A placebo tablet study evaluated formulation and geometry in relation to split weight uniformity. Its specific observations should not be turned into a universal shape rule. For the supplement project, ask which comparisons can clarify the proposed design and what finished product information is still needed before approving directions involving split portions.
Review handling and labeling together
Discuss whether dividing the tablet creates fragments or changes the appearance the consumer will see. Review the instructions and any proposed handling of unused portions with the qualified team. Avoid adding unsupported storage or use advice from a general design preference. The actual product and package need to support the intended experience.
Check sample labels, drawings, and artwork drafts for consistent wording. If the groove is decorative, make sure the product copy does not quietly present it as permission to divide a serving. If splitting is intended, confirm that the approved evidence and instructions describe the same tablet revision and the same planned consumer action.
Keep the design tied to controlled revisions
Record the approved tooling, formula, surface finish, and evaluation reports as one design package. Ask what happens if tablet geometry, material grade, or finishing changes on a repeat order. A score line can remain visually similar while the broader product configuration changes, so retain the review rationale alongside the drawing.
Before accepting a later substitution, have the qualified reviewer determine whether existing evidence still applies to the intended split function. Keep the outcome explicit in the change record. This approach makes the product’s claimed use traceable to evidence instead of relying on a groove that happens to look familiar on a newly revised sample.
Common questions
Does a score line prove equal ingredient amounts in each half?
No. Its intended function needs suitable evidence for the actual product and the relevant portions.
Can score line evidence be transferred to a different formula?
The qualified technical reviewer should assess whether the change affects the intended function and whether additional evaluation is needed.
Sources & further reading
- FDA laboratory study of scored and unscored pharmaceutical tablet uniformity
- Formulation variables and weight uniformity of scored placebo tablets
These sources support the general technical context. They do not verify the credentials or capacity of a specific factory. This guide is for manufacturing planning; it does not provide medical advice or product efficacy claims.